Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
AB Sciex

Novel Cell Sieve Reduces Risk of Contamination During Filtration of Cell Suspensions and Primary Cell Isolates

By Labmedica International staff writers
Posted on 15 Aug 2013
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
A novel sterile, single-use cell sieve is ideal for preparing single cells for flow cytometry and to separate individual cells after organ digestion as part of the primary cell extraction process.

Greiner Bio-One (Kremsmuenster, Austria), a company that has focused on the development, production, and distribution of plastic laboratory products, has introduced EASYstrainer, a cell sieve for the filtration of cell suspensions.

To prevent sterile filter material from becoming contaminated through accidental contact EASYstrainer was designed with a circumferential mantle surface and handle fitted directly on the sieve. The unit is sealed in blister packaging that ensures reliable, aseptic removal of sieves from the pack.

The EASYstrainer features a venting slot between the collection tube and the attached cell sieve. Air in the tube escapes through this slot during the rapid filtration step, and overflow is avoided. This special property prevents the accumulation of filtration liquid between the sieve and tube and thus the associated risk of contamination.

EASYstrainer is suitable for all standard 50 ml tubes and is available in mesh widths of 40, 70, and 100 microliters.

Related Links:
Greiner Bio-One


DRG International
77 ELEKTRONIKA
DiagCor Bioscience
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel

Heart Attack Biomarkers Accurate in Chronic Kidney Disease Patients

Two blood peptide biomarkers that are indicators of heart attack in the general population also provide critical information regarding heart status in chronic kidney disease patients. High-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) strongly predict heart failure (HF) in the... Read more

Industry News

view channel

GlaxoSmithKline Boosts Global Cancer Testing With GE Healthcare Deal

The new agreement between GE Healthcare-subsidiary Clarient (Aliso Viejo, CA, USA) and GlaxoSmithKline (GSK; Brentford, UK) will create a force in cancer testing, according to Kalorama Information (New York City, NY, USA). The two entities will form a multipurpose, data analytics- and companion diagnostics (CDx)-driven... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.